Director SKIMS Lauds First Successful Infant Bone Marrow Transplant Performed at SKIMS in an Eight-Month-Old Child
Srinagar May 16: Director SKIMS/EOSG Prof. (Dr.) M. Ashraf Ganie congratulated the Department of Clinical Hematology and Bone Marrow Transplant (BMT) at Sher-i-Kashmir Institute of Medical Sciences for successfully performing the first infant Hematopoietic Stem Cell Transplant (Bone Marrow Transplant) in an eight-month-old child diagnosed with Hemophagocytic Lymphohistiocytosis (HLH), a rare and life-threatening immune disorder.
He described the achievement as a major milestone in advanced cellular therapy and bone marrow transplantation services in the Union Territory of Jammu & Kashmir and appreciated the dedicated efforts of the transplant team and reiterated the institute’s commitment towards strengthening and expanding world-class hematology and transplant care facilities within the region.
The infant had been suffering from severe manifestations of HLH, a condition characterized by uncontrolled immune system activation leading to persistent fever, multiorgan involvement, and potentially fatal complications. For children affected with this disorder, Hematopoietic Stem Cell Transplantation remains the only curative treatment option. Without timely transplant intervention, survival in such infants remains extremely poor.
Following extensive evaluation and meticulous multidisciplinary planning, the child successfully underwent the stem cell transplant and is being discharged today in a stable condition.
Dr. Sajad Ahmad Geelani, Professor & Head, Department of Clinical Hematology and BMT, stated that this landmark achievement marks a major milestone for the transplant programme at SKIMS and reflects the institution’s growing expertise in managing highly complex disorders requiring advanced cellular therapies.
Dr. Reashma Roshan, Associate Professor, Department of Clinical Hematology and BMT, stated that performing a transplant in such a young infant requires exceptional clinical precision, highly specialized infrastructure, and comprehensive supportive care throughout the transplant journey. She added that the successful outcome reflects the dedicated efforts of hematology and bone marrow transplant specialists, pediatric intensive care experts, nursing staff, transfusion medicine services, laboratory teams, and allied healthcare professionals.
Dr. Afaq Ahmad Khan, Assistant Professor, Department of Clinical Hematology and BMT, stated that this accomplishment represents new hope for children suffering from rare immunological and hematological disorders and reinforces the institution’s commitment to providing state-of-the-art transplant services within the region.
At the time of discharge, Director SKIMS Prof. M. Ashraf Ganie personally interacted with the child’s family and expressed satisfaction and happiness over the successful outcome. He congratulated the entire transplant team for achieving this important milestone in cellular therapy at the institute.
The Department of Clinical Hematology expressed sincere gratitude to the Director, SKIMS, for his constant support, encouragement, and vision in strengthening advanced hematology and transplant services at the institute.
The family of the child expressed profound gratitude to the medical team and the institute for their dedicated care, support, and compassionate management throughout this challenging journey.
The Department of Clinical Hematology also acknowledged the invaluable contribution of all allied departments and support services whose coordinated efforts were instrumental in the successful completion of this highly complex transplant procedure. Special appreciation was conveyed to the Departments of Pediatric Intensive Care, particularly Dr. Zubair Mushtaq Trumboo, Assistant Professor, Department of Pediatrics, along with the Departments of Transfusion Medicine, Microbiology, Pathology, Immunology, Anesthesiology, Radiology, Nursing Services, Infection Control Team, laboratory personnel, and all allied healthcare workers for their unwavering dedication, teamwork, and round-the-clock support.
Press Release
Director SKIMS Lauds First Successful Infant Bone Marrow Transplant Performed at SKIMS in an Eight-Month-Old Child
Director SKIMS/EOSG Prof. (Dr.) M. Ashraf Ganie congratulated the Department of Clinical Hematology and Bone Marrow Transplant (BMT) at Sher-i-Kashmir Institute of Medical Sciences for successfully performing the first infant Hematopoietic Stem Cell Transplant (Bone Marrow Transplant) in an eight-month-old child diagnosed with Hemophagocytic Lymphohistiocytosis (HLH), a rare and life-threatening immune disorder.
He described the achievement as a major milestone in advanced cellular therapy and bone marrow transplantation services in the Union Territory of Jammu & Kashmir and appreciated the dedicated efforts of the transplant team and reiterated the institute’s commitment towards strengthening and expanding world-class hematology and transplant care facilities within the region.
The infant had been suffering from severe manifestations of HLH, a condition characterized by uncontrolled immune system activation leading to persistent fever, multiorgan involvement, and potentially fatal complications. For children affected with this disorder, Hematopoietic Stem Cell Transplantation remains the only curative treatment option. Without timely transplant intervention, survival in such infants remains extremely poor.
Following extensive evaluation and meticulous multidisciplinary planning, the child successfully underwent the stem cell transplant and is being discharged today in a stable condition.
Dr. Sajad Ahmad Geelani, Professor & Head, Department of Clinical Hematology and BMT, stated that this landmark achievement marks a major milestone for the transplant programme at SKIMS and reflects the institution’s growing expertise in managing highly complex disorders requiring advanced cellular therapies.
Dr. Reashma Roshan, Associate Professor, Department of Clinical Hematology and BMT, stated that performing a transplant in such a young infant requires exceptional clinical precision, highly specialized infrastructure, and comprehensive supportive care throughout the transplant journey. She added that the successful outcome reflects the dedicated efforts of hematology and bone marrow transplant specialists, pediatric intensive care experts, nursing staff, transfusion medicine services, laboratory teams, and allied healthcare professionals.
Dr. Afaq Ahmad Khan, Assistant Professor, Department of Clinical Hematology and BMT, stated that this accomplishment represents new hope for children suffering from rare immunological and hematological disorders and reinforces the institution’s commitment to providing state-of-the-art transplant services within the region.
At the time of discharge, Director SKIMS Prof. M. Ashraf Ganie personally interacted with the child’s family and expressed satisfaction and happiness over the successful outcome. He congratulated the entire transplant team for achieving this important milestone in cellular therapy at the institute.
The Department of Clinical Hematology expressed sincere gratitude to the Director, SKIMS, for his constant support, encouragement, and vision in strengthening advanced hematology and transplant services at the institute.
The family of the child expressed profound gratitude to the medical team and the institute for their dedicated care, support, and compassionate management throughout this challenging journey.
The Department of Clinical Hematology also acknowledged the invaluable contribution of all allied departments and support services whose coordinated efforts were instrumental in the successful completion of this highly complex transplant procedure. Special appreciation was conveyed to the Departments of Pediatric Intensive Care, particularly Dr. Zubair Mushtaq Trumboo, Assistant Professor, Department of Pediatrics, along with the Departments of Transfusion Medicine, Microbiology, Pathology, Immunology, Anesthesiology, Radiology, Nursing Services, Infection Control Team, laboratory personnel, and all allied healthcare workers for their unwavering dedication, teamwork, and round-the-clock support.
